№ lp_2_3_58015
File format: docx Character count: 8378 File size: 30 KB
Year: 2025
Region / city: Not specified
Topic: Achondroplasia, FGFR3, Tyrosine Kinase Inhibitors, Genetic Disorders
Document Type: Research Letter
Organization: Not specified
Author(s): Not specified
Target Audience: Medical professionals, researchers
Period of validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Contextual description: A research letter summarizing recent advancements in the treatment and genetic understanding of achondroplasia, particularly focusing on selective FGFR3 tyrosine kinase inhibitors.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease
Year: 2015
Region / City: Zurich, Switzerland
Topic: Inflammatory bowel disease
Document type: Journal Article
Organization / Institution: University Hospital Zurich, University of California Riverside
Author: Marianne R Spalinger, Declan F McCole, Gerhard Rogler, Michael Scharl
Target audience: Researchers, medical professionals
Period of validity: N/A
Approval date: N/A
Modification date: N/A
Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis
Journal: World Journal of Gastroenterology
Manuscript NO: 90838
Manuscript Type: Letter to the Editor
Authors: Francesca Colapietro, Nicola Pugliese, Antonio Voza, Alessio Aghemo, Stella De Nicola
Affiliations: Department of Biomedical Sciences, Humanitas University, Milan, Italy; Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Research Hospital, Milan, Italy; Department of Emergency, Humanitas Research Hospital, Milan, Italy
Corresponding Author: Francesca Colapietro, MD, Department of Biomedical Sciences, Humanitas University, Milan, Italy, [email protected]
Received: December 15, 2023
Revised: January 11, 2024
Accepted: February 18, 2024
Keywords: Chronic hepatitis B, Reactivation, Nucleoside analogue, Tyrosine kinase inhibitors, Onco-hematology
Study Type: Case report and literature review
Patient Details: 67-year-old Caucasian male with chronic lymphocytic leukemia, HBsAg-/anti-HBc+
Treatment: Tyrosine kinase inhibitors, specifically acalabrutinib
Clinical Outcome: HBV reactivation with liver failure, treated with nucleos(t)ide analogues
Comparative Analysis of Cluster A Mycobacteriophage Serine and Tyrosine Integrases
Year: 2024
Region / City: Longview, TX
Theme: Mycobacteriophages, Serine Integrase, Tyrosine Integrase
Document Type: Research Paper
Author: Megan T LeBlanc, Varma Parinita, Josh D McLoud, Frederick N Baliraine
Target Audience: Scientists, Researchers in Biotechnology and Genetic Engineering
Period of Action: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Topics: Achondroplasia FGFR3 tyrosine